Company Filing History:
2 out of 134 
1 out of 832,880 Years Active: 2004-2015
Title: Innovations and Contributions of Inventor Ching-Shyang Chen
Introduction
Ching-Shyang Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in understanding and combating breast cancer. With a total of 3 patents, his work focuses on innovative methods to inhibit cancer cell proliferation.
Latest Patents
One of his latest patents is titled "Method of identifying a candidate compound which may inhibit α9-nAChR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells." This invention relates to methods for identifying compounds that can inhibit the overexpression of α9-nAChR and estrogen receptor-dependent transcription in breast cancer cells induced by nicotine. The research highlights the role of α9-nAChR in the response to both endogenous and exogenous stimulation, emphasizing its significance in cancer progression.
Another important patent by Chen is "Small interfering RNAs and methods for prevention, inhibition and/or treatment of malignant progression of breast cancer." This invention addresses the overexpression and activation of α9-nAChR, which are linked to breast cancer tumorigenesis. The patent provides small interfering RNAs (siRNAs) designed to inhibit α9-nAChR expression, offering potential methods for preventing and treating malignant progression in breast cancer.
Career Highlights
Ching-Shyang Chen has worked at Taipei Medical University, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of cancer biology and developing therapeutic strategies.
Collaborations
Chen has collaborated with notable colleagues, including Chia-Hwa Lee and Shih-Hsin Tu, who have contributed to his research endeavors.
Conclusion
Ching-Shyang Chen's innovative patents and research contributions have made a significant impact in the field of cancer research. His work continues to pave the way for new therapeutic approaches to combat breast cancer.